OralGLP-1 & Metabolic

Orforglipron

Name: Orforglipron
Brand: Prime Bio Group

A non-peptide small molecule GLP-1 receptor agonist built for oral bioavailability — no reconstitution, no needle, no cold chain.

For research use only · not for human consumption

Single unit$105Order at Prime →

View Orforglipron at Prime Bio Group →

Orders are placed, processed, and shipped by Prime Bio Group. Fresno Peptide Lab does not stock or sell product — we may earn a commission at no extra cost to you.

Independent research on Orforglipron. Our sister publication Peptides Uncaged maintains a plain-English research guide covering mechanism, the published literature, and how vendors are scored on purity and COA transparency. It is written independently of any lab. How to read a COA is worth ten minutes before your first order.

The research

What Orforglipron is being studied for

Orforglipron is an oral, non-peptide small molecule that functions as a selective glucagon-like peptide-1 receptor agonist (GLP-1RA). Unlike traditional peptide-based GLP-1 therapies, Orforglipron is structurally designed for oral bioavailability, eliminating the need for subcutaneous injections. It acts on the GLP-1 receptor to enhance insulin secretion, suppress glucagon release, slow gastric emptying, and reduce appetite.

In research settings, Orforglipron has been widely studied for its effects on weight management, glycemic control, and metabolic regulation. Early investigations highlight its potential as a once-daily oral GLP-1 agonist, offering improved patient compliance and accessibility compared to injectable options. Potential applications of Orforglipron research include:

Where it is being applied in research

Weight management studies through appetite suppression and reduced caloric intake
Type 2 diabetes research with focus on insulin sensitivity and glucose regulation
Metabolic health investigations including obesity-related comorbidities
Cardiovascular risk reduction through improved glycemic control and weight loss Orforglipron remains a focus of ongoing research in endocrinology, diabetes management, obesity interventions, and cardiometabolic health. ORFORGLIPRON COA

Summary of published preclinical and clinical literature, provided for research context only. Not a claim of efficacy and not medical advice.

Common questions

Orforglipron — FAQ

What is Orforglipron?

A non-peptide small molecule GLP-1 receptor agonist built for oral bioavailability — no reconstitution, no needle, no cold chain.

What formats does Orforglipron come in?

Prime Bio Group supplies Orforglipron as oral. Available options: Single unit at $105.

Is there a certificate of analysis for Orforglipron?

Yes. Prime Bio Group is a physician-owned lab and provides a certificate of analysis on every batch. A COA reports identity by mass spectrometry and purity by HPLC — if you are not sure how to read one, our guide on reading a certificate of analysis walks through it line by line.

Also in GLP-1 & Metabolic